GX Acquisition Corp. at its special meeting held on July 14, 2021, elected Peter Diamandis, M.D., Peter Diamandis, M.D, Lim Kok Thay, John Sculley, Robin L. Smith, M.D, Andrew C. von Eschenbach, M.D and Jay R. Bloom as directors effective upon the closing of the Business Combination, staggered terms on the Board until the 2022, 2023 and 2024 annual meetings of stockholders, respectively, and until their respective successors are duly elected and qualified.